LGM

Logos Global Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 90.41%
This Quarter Est. Return
1 Year Est. Return
+90.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$749M
AUM Growth
+$186M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
60
New
Increased
Reduced
Closed

Top Buys

1
+$47.8M
2
+$25.1M
3
+$24.4M
4
ARVN icon
Arvinas
ARVN
+$24.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$18.9M

Top Sells

1
+$35.5M
2
+$26.1M
3
+$21.8M
4
BNTX icon
BioNTech
BNTX
+$18.2M
5
ETNB
89bio
ETNB
+$18.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLTX icon
26
MoonLake Immunotherapeutics
MLTX
$905M
$9.44M 1.04%
200,000
-150,000
CDTX icon
27
Cidara Therapeutics
CDTX
$6.84B
$9.25M 1.02%
+190,000
CBIO
28
Crescent Biopharma
CBIO
$219M
$8.94M 0.99%
553,686
+499,686
LEGN icon
29
Legend Biotech
LEGN
$5.59B
$8.87M 0.98%
+250,000
RYTM icon
30
Rhythm Pharmaceuticals
RYTM
$6.63B
$8.21M 0.91%
+130,000
MAZE
31
Maze Therapeutics
MAZE
$1.57B
$7.51M 0.83%
611,914
-325,000
ELVN icon
32
Enliven Therapeutics
ELVN
$1.31B
$7.02M 0.78%
350,000
+110,000
JBIO
33
Jade Biosciences
JBIO
$492M
$6.24M 0.69%
625,000
+585,000
ANNX icon
34
Annexon
ANNX
$324M
$5.78M 0.64%
2,410,000
-1,590,000
MTSR
35
Metsera Inc
MTSR
$7.43B
$5.69M 0.63%
+200,000
TRVI icon
36
Trevi Therapeutics
TRVI
$1.38B
$4.65M 0.51%
850,000
+425,285
IMVT icon
37
Immunovant
IMVT
$4.16B
$4.4M 0.49%
275,000
VSTM icon
38
Verastem
VSTM
$504M
$4.15M 0.46%
+1,000,000
ATXS icon
39
Astria Therapeutics
ATXS
$718M
$3.75M 0.42%
700,000
+200,000
BCAX
40
Bicara Therapeutics
BCAX
$810M
$3.72M 0.41%
+400,000
ACRS icon
41
Aclaris Therapeutics
ACRS
$273M
$2.63M 0.29%
1,850,000
-372,222
RAPP
42
Rapport Therapeutics
RAPP
$1.16B
$2.38M 0.26%
208,910
UNCY icon
43
Unicycive Therapeutics
UNCY
$100M
$2.26M 0.25%
473,562
-34,331
SEPN
44
Septerna Inc
SEPN
$1.04B
$1.15M 0.13%
109,202
-25,000
NUVB.WS icon
45
Nuvation Bio Inc Warrants
NUVB.WS
$32.5M
$18K ﹤0.01%
66,666
XENE icon
46
Xenon Pharmaceuticals
XENE
$3.15B
– –
-650,000
CRNX icon
47
Crinetics Pharmaceuticals
CRNX
$4.05B
– –
-350,000
ETNB
48
DELISTED
89bio
ETNB
– –
-2,500,000
GERN icon
49
Geron
GERN
$715M
– –
-8,000,000
LRMR icon
50
Larimar Therapeutics
LRMR
$289M
– –
0
1
2
3